Showing results (81-90 of 285) with videos related to
Sort By:
Pageof 29
Breast Cancer Research and Treatment|June 26, 2026
Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimenRiya Albert, Joshua Thomas, Navid Sadeghi, et al.American Journal of Preventive Medicine|August 2, 2025
Patterns of Breast Cancer Screening and Access to Care in a Safety-Net SystemMalcolm Su, Shifa Kanjwal, Madeleine Hopson, et al.JCO Oncology Practice|May 16, 2025
Early Integration of Outpatient Palliative Care Among Adults With Advanced Cancer in a Safety-Net Health System: A Patterns of Care AnalysisLisa DiMartino, Vincent Merrill, Celette Sugg Skinner, et al.Oncology Nursing Forum|February 22, 2017
Oncology Nursing Perceptions of Patient Electronic Portal Use: A Qualitative AnalysisDavid E Gerber, Muhammad Shaalan Beg, Tobi Duncan, et al.Lung|August 2, 2019
Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based AnalysisMitchell S von Itzstein, Arjun Gupta, Kristin C Mara, et al.The Oncologist|April 2, 2020
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung CancerVinita Popat, Rong Lu, Murtaza Ahmed, et al.Journal of the National Cancer Institute|September 26, 2014
Impact of prior cancer on eligibility for lung cancer clinical trialsDavid E Gerber, Andrew L Laccetti, Lei Xuan, et al.Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysisAndrew L Laccetti, Sandi L Pruitt, Lei Xuan, et al.Journal of the National Cancer Institute|February 11, 2015
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrualAndrew L Laccetti, Sandi L Pruitt, Lei Xuan, et al.The Oncologist|May 29, 2015
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved PopulationsDavid E Gerber, Ashley M Lakoduk, Laurin L Priddy, et al.Pageof 29